WO1997018840A3 - Liberation d'agents therapeutiques au moyen de composes auto-assembles pour former des microstructures a rapport axial eleve_ - Google Patents

Liberation d'agents therapeutiques au moyen de composes auto-assembles pour former des microstructures a rapport axial eleve_ Download PDF

Info

Publication number
WO1997018840A3
WO1997018840A3 PCT/US1996/018850 US9618850W WO9718840A3 WO 1997018840 A3 WO1997018840 A3 WO 1997018840A3 US 9618850 W US9618850 W US 9618850W WO 9718840 A3 WO9718840 A3 WO 9718840A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic
assembled
harfm
high axial
axial ratio
Prior art date
Application number
PCT/US1996/018850
Other languages
English (en)
Other versions
WO1997018840A2 (fr
Inventor
Paul Yager
Michael H Gelb
Paul A Carlson
Anatoly N Lukyanov
Alex S Goldstein
Kyujin C Lee
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Priority to AU12738/97A priority Critical patent/AU1273897A/en
Publication of WO1997018840A2 publication Critical patent/WO1997018840A2/fr
Publication of WO1997018840A3 publication Critical patent/WO1997018840A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6919—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a ribbon or a tubule cochleate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des agents thérapeutiques comprenant plusieurs composés thérapeutiques auto-assemblés pour former des microstructures à rapport axial élevé. Lesdits composés thérapeutiques correspondant à la formule HARFM-Th, HARFM étant un matériau à rapport axial élevé et Th une substance thérapeutique associée à celui-ci. L'agent thérapeutique peut également correspondre à la formule HARFM-S-Th, S étant un espaceur. La libération de la substance thérapeutique par l'agent suit généralement une cinétique d'ordre 0 ou une pseudo-cinétique de premier ordre. L'invention porte également sur un procédé d'administration d'une dose efficace d'une substance thérapeutique auto-assemblée pour former une microstructure HAR, à un animal ou à une personne.
PCT/US1996/018850 1995-11-22 1996-11-21 Liberation d'agents therapeutiques au moyen de composes auto-assembles pour former des microstructures a rapport axial eleve_ WO1997018840A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU12738/97A AU1273897A (en) 1995-11-22 1996-11-21 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2513795P 1995-11-22 1995-11-22
US60/025,137 1995-11-22

Publications (2)

Publication Number Publication Date
WO1997018840A2 WO1997018840A2 (fr) 1997-05-29
WO1997018840A3 true WO1997018840A3 (fr) 1997-10-09

Family

ID=21824258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/018850 WO1997018840A2 (fr) 1995-11-22 1996-11-21 Liberation d'agents therapeutiques au moyen de composes auto-assembles pour former des microstructures a rapport axial eleve_

Country Status (2)

Country Link
AU (1) AU1273897A (fr)
WO (1) WO1997018840A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180114B1 (en) * 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
WO2009074569A1 (fr) * 2007-12-11 2009-06-18 Bracco International Bv Composés de ciblage et thérapeutiques avec un espaceur comprenant de la polyproline et microvésicules remplies de gaz comprenant lesdits composés
CN106083637B (zh) * 2016-06-06 2018-11-23 大连民族大学 味精类脂、味精脂质体的合成方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004566A (en) * 1987-02-06 1991-04-02 Geo-Centers, Inc. Process for fabrication of lipid microstructures from dry organic solvent
WO1996025942A1 (fr) * 1995-02-22 1996-08-29 Albany Medical College Phospholipides cochleaires utilises dans l'administration de medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004566A (en) * 1987-02-06 1991-04-02 Geo-Centers, Inc. Process for fabrication of lipid microstructures from dry organic solvent
WO1996025942A1 (fr) * 1995-02-22 1996-08-29 Albany Medical College Phospholipides cochleaires utilises dans l'administration de medicaments

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
ARCHIBALD, DOUGLAS DEAN ET AL: "Structural studies of lipid fibers formed by sphingosine", BIOCHIM. BIOPHYS. ACTA (1993), 1166(2-3), 154-62 CODEN: BBACAQ;ISSN: 0006-3002, 1993, XP002035252 *
CHEMICAL ABSTRACTS, vol. 119, no. 14, 4 October 1993, Columbus, Ohio, US; abstract no. 146454, SPARGO, BARRY J. ET AL: "Technological development of lipid-based microcylinders: biocompatibility and controlled release" XP002035255 *
CHEMICAL ABSTRACTS, vol. 126, Columbus, Ohio, US; abstract no. 340085, HARTGERINK, JEFFREY D. ET AL: "Self assembling organic nanotubes" XP002035256 *
ITOJIMA, YUKIKO ET AL: "Helical structures of nucleic acid - lipid conjugates: formation and morphology of helical structures from dimyristoyl-5'-phosphatidylribonucleosides", NUCLEIC ACIDS SYMP. SER. (1990), 22(SYMP. NUCLEIC ACIDS TECHNOL., 1990), 123-4 CODEN: NACSD8;ISSN: 0261-3166, 1990, XP002035254 *
ITOJIMA, YUKIKO ET AL: "Spontaneous formation of helical structures from phospholipid-nucleoside conjugates", BIOCHEMISTRY (1992), 31(20), 4757-65 CODEN: BICHAW;ISSN: 0006-2960, 1992, XP002035253 *
J.M. SCHNUR ET AL.: "Development of self-assembled lipid microcylinders for controlled release applications2", PHARM. NEWS (LANGHORNE, PA.) (1995), 2(1), 10-15 CODEN: PHNEEP;ISSN: 1071-894X, vol. 2, no. 1, 1995, pages 10 - 15, XP002035459 *
MATER. RES. SOC. SYMP. PROC. (1992), 252(TISSUE-INDUCING BIOMATERIALS), 285-91 CODEN: MRSPDH;ISSN: 0272-9172, 1992 *
NEW MACROMOL. ARCHIT. FUNCT., PROC. OUMS'95, 2ND (1996), MEETING DATE 1995, 181-188. EDITOR(S): KAMACHI, MIKIHARU;NAKAMURA, AKIRA. PUBLISHER: SPRINGER, BERLIN, GERMANY. CODEN: 64HZAA, 1996 *
PRICE R ET AL: "CONTROLLED RELEASE FROM CYLINDRICAL MICROSTRUCTURES", JOURNAL OF MICROENCAPSULATION, vol. 8, no. 3, 1 July 1991 (1991-07-01), pages 301 - 306, XP000220220 *
SPARGO, B. J. ET AL: "Controlled release of transforming growth factor-.beta. from lipid-based microcylinders", J. MICROENCAPSULATION (1995), 12(3), 247-54 CODEN: JOMIEF;ISSN: 0265-2048, 1995, XP002035251 *

Also Published As

Publication number Publication date
AU1273897A (en) 1997-06-11
WO1997018840A2 (fr) 1997-05-29

Similar Documents

Publication Publication Date Title
CA2184242A1 (fr) Systeme de ciblage d'un medicament, procede de preparation et utilisation de ce medicament
AU1227899A (en) Osmotic medicament releasing system
WO2001043749A3 (fr) Implant pharmacologique contenant des composants a liberation immediate et a liberation prolongee et procede d'administration
TR200001998T1 (tr) Kontrollü salıverilen tolterodin uygulamak için ilaç formülasyonu
CA2226870A1 (fr) Administration epidurale de composes therapeutiques avec une vitesse faible de liberation
HUT56290A (en) Plaster of oestrogenic active ingredient content and method for producing same
CA2298238A1 (fr) Liberation controlee par extrusion de dispersions solides amorphes de medicaments
ES2111304T3 (es) Composicion de administracion por via nasal de un medicamento que contiene nicotina.
NZ234881A (en) Biphasic transdermal drug delivery device
MY131733A (en) Aerosol drug formulations
NO962833L (no) Transdermalt preparat omfattende polyvinylpyrrolidin
AU1534699A (en) Osmotic dosage form comprising first and second coats
WO2003077972A3 (fr) Systeme de distribution de medicament implantable
EP1738751A3 (fr) système de libération espacée de médicaments
CA2046014A1 (fr) Reduction ou prevention des irritations cutanees causees par des medicaments
WO1992002234A3 (fr) Reduction ou prevention du phenomene de sensibilisation aux medicaments
EP0160501A3 (fr) Composé intranasal à effet prolongé et méthode d'utilisation
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO1994017792A3 (fr) Compositions et procedes d'administration transdermique de medicaments
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
WO1997018840A3 (fr) Liberation d'agents therapeutiques au moyen de composes auto-assembles pour former des microstructures a rapport axial eleve_
EP0325086A3 (fr) Méthodes pour obtenir des systèmes thérapeutiques à libération contrôlée du médicament
WO1993017691A3 (fr) Compositions pharmaceutiques contenant du monosialoganglioside gm1 ou un derive de celui-ci, convenant ou traitement de la maladie de parkinson
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97519955

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA